| Lactose (India) Ltd | 151 Cr. | 120 | 247/84.3 | 34.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,930 Cr. | 452 | 465/192 | 111 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 37.1 Cr. | 50.0 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 30.6 Cr. | 20.9 | 29.1/17.0 | 31.9 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 65.3 Cr. | 86.7 | 134/78.9 | 17.2 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,327 Cr. | 1,819 | 2,286/1,275 | 38.5 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 332 Cr. | 14.6 | 22.5/10.8 | 20.2 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 792 Cr. | 1,678 | 1,696/635 | 33.8 | 299 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 115 Cr. | 23.0 | 32.0/15.0 | 35.1 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 801 Cr. | 272 | 449/219 | 7.66 | 123 | 0.92 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 14.9 Cr. | 5.97 | 9.28/2.11 | 8.45 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 390 Cr. | 402 | 477/112 | 62.8 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,732 Cr. | 1,088 | 1,584/1,045 | 46.1 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 61.4 Cr. | 0.30 | 1.24/0.30 | 4.04 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 48.6 Cr. | 20.2 | 26.3/6.40 | 50.1 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.68 Cr. | 9.58 | 17.2/9.40 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 177 Cr. | 496 | 896/443 | 9.59 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 66.9 Cr. | 66.9 | 71.2/26.1 | 172 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,426 Cr. | 1,474 | 2,452/1,345 | 43.2 | 173 | 0.73 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.4 Cr. | 42.4 | 88.7/37.6 | 40.3 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 16.1 Cr. | 6.45 | 6.45/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.6 Cr. | 124 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 33.8 Cr. | 61.8 | 63.1/9.41 | 376 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.16 Cr. | 20.5 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,183 Cr. | 645 | 1,028/464 | 31.2 | 65.3 | 0.19 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 89.6 Cr. | 20.8 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.1 Cr. | 23.8 | 43.7/17.4 | 52.6 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 1,00,399 Cr. | 2,432 | 3,055/2,115 | 55.5 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 250 Cr. | 435 | 524/241 | 26.2 | 119 | 1.03 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 56.7 Cr. | 39.5 | 62.6/31.6 | 51.1 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 63,574 Cr. | 1,085 | 1,443/994 | 18.8 | 557 | 0.37 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 135 Cr. | 216 | 303/170 | 195 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 871 Cr. | 86.9 | 123/74.0 | 18.9 | 32.5 | 1.73 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 41.7 Cr. | 31.9 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,781 Cr. | 1,683 | 1,868/754 | 61.5 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.45/0.55 | 80.6 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 250 Cr. | 32.6 | 68.0/30.0 | 13.3 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 9.01 Cr. | 15.4 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 63,601 Cr. | 29,930 | 37,000/25,260 | 43.8 | 1,992 | 1.59 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,545 Cr. | 832 | 972/550 | 28.3 | 220 | 0.60 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 250 Cr. | 88.0 | 90.4/31.3 | 60.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,615 Cr. | 1,522 | 1,628/535 | | 104 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,650 Cr. | 1,332 | 1,870/1,045 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 774 Cr. | 235 | 330/154 | 18.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 589 Cr. | 441 | 568/270 | 12.6 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,303 Cr. | 469 | 950/455 | 26.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,627 Cr. | 1,152 | 1,616/991 | 23.0 | 768 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,21,205 Cr. | 3,581 | 3,790/2,886 | 60.0 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,164 Cr. | 126 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,567 Cr. | 16.7 | 24.0/14.1 | 27.5 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 33,528 Cr. | 876 | 1,360/856 | 95.4 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,542 Cr. | 200 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,07,647 Cr. | 1,699 | 1,924/1,547 | 35.6 | 301 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,648 Cr. | 591 | 886/441 | 108 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,639 Cr. | 298 | 319/175 | 37.6 | 75.9 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 339 Cr. | 1,122 | 1,680/956 | 19.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,111 Cr. | 364 | 502/265 | 55.3 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,087 Cr. | 202 | 232/111 | 169 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,852 Cr. | 4,712 | 6,899/4,146 | 30.4 | 340 | 2.48 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,895 Cr. | 2,355 | 2,776/1,772 | 34.9 | 335 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,098 Cr. | 6,084 | 6,739/4,863 | 33.6 | 323 | 2.05 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 173 Cr. | 49.0 | 87.5/32.5 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 24,434 Cr. | 5,341 | 5,993/3,701 | 36.1 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 8.74 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,700 Cr. | 441 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,653 Cr. | 720 | 1,998/604 | 42.9 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,641 Cr. | 16,088 | 18,100/10,060 | 157 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 305 Cr. | 13.6 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,775 Cr. | 825 | 1,505/660 | 8.70 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,676 Cr. | 48.8 | 91.7/41.7 | 28.9 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,007 Cr. | 177 | 359/162 | 22.9 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 108 Cr. | 68.2 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 339 Cr. | 95.0 | 177/90.2 | 45.2 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 88,209 Cr. | 1,931 | 2,403/1,774 | 23.8 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,056 Cr. | 527 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 50,009 Cr. | 926 | 950/460 | 73.2 | 91.1 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 949 Cr. | 915 | 1,235/596 | 21.8 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 153 Cr. | 71.0 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 820 Cr. | 170 | 327/154 | 23.5 | 107 | 1.77 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 646 Cr. | 370 | 500/265 | 23.1 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,819 Cr. | 1,119 | 1,310/802 | 36.7 | 393 | 0.45 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,656 Cr. | 1,702 | 1,998/1,303 | 38.9 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,439 Cr. | 216 | 328/179 | 33.7 | 36.1 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 32,187 Cr. | 1,269 | 1,758/1,168 | 36.0 | 274 | 0.32 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,727 Cr. | 92.9 | 127/57.5 | 25.9 | 57.5 | 0.86 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 749 Cr. | 102 | 124/67.2 | 34.0 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,595 Cr. | 281 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,996 Cr. | 243 | 465/236 | 47.3 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,433 Cr. | 1,685 | 2,786/1,243 | 38.1 | 369 | 0.42 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,427 Cr. | 342 | 504/285 | 56.0 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,700 Cr. | 565 | 628/412 | 28.7 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,327 Cr. | 1,819 | 2,286/1,275 | 38.5 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,724 Cr. | 2,758 | 3,516/1,921 | 49.3 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,986 Cr. | 1,941 | 2,131/1,200 | 28.2 | 592 | 0.93 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,005 Cr. | 430 | 559/359 | 26.0 | 140 | 1.16 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,557 Cr. | 1,583 | 1,910/1,097 | 55.7 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,131 Cr. | 1,284 | 1,406/1,020 | 18.6 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,451 Cr. | 284 | 322/170 | 37.5 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,27,982 Cr. | 1,584 | 1,673/1,310 | 23.7 | 386 | 0.82 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,150 Cr. | 1,993 | 2,641/1,551 | 26.8 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 334 Cr. | 113 | 203/95.6 | 164 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,617 Cr. | 153 | 191/105 | 15.2 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 63.4 Cr. | 39.0 | 73.3/38.0 | 22.7 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 48,064 Cr. | 360 | 406/291 | 133 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,817 Cr. | 1,800 | 2,215/1,430 | 39.7 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 133 Cr. | 83.8 | 141/76.3 | 18.6 | 48.6 | 1.43 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 320 Cr. | 135 | 179/67.8 | 31.8 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 23,256 Cr. | 9,302 | 10,691/6,220 | 110 | 308 | 0.34 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,073 Cr. | 717 | 843/544 | 38.0 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 188 Cr. | 89.3 | 137/85.0 | 7.13 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,299 Cr. | 5,545 | 6,084/4,492 | 29.2 | 1,002 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,174 Cr. | 925 | 1,156/725 | 30.6 | 264 | 1.19 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 457 Cr. | 801 | 1,540/763 | 72.7 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 30,164 Cr. | 2,414 | 3,181/2,022 | 32.4 | 303 | 1.16 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,432 Cr. | 307 | 509/258 | 25.1 | 127 | 1.70 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,541 Cr. | 494 | 575/312 | 25.4 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,852.77 Cr | 1,184.72 | | 50.24 | 194.36 | 0.34% | 16.24% | 14.95% | 6.10 |